Production (Stage)
cbdMD, Inc.
YCBD
$0.8579
-$0.0011-0.13%
AMEX
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -9.22% | -18.02% | -19.35% | -21.55% | -25.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -9.22% | -18.02% | -19.35% | -21.55% | -25.00% |
| Cost of Revenue | -8.37% | -12.93% | -18.43% | -23.83% | -21.80% |
| Gross Profit | -9.72% | -20.90% | -19.91% | -20.17% | -26.79% |
| SG&A Expenses | -25.60% | -28.41% | -28.23% | -29.44% | -28.73% |
| Depreciation & Amortization | -28.33% | -31.80% | -36.15% | -3.69% | -1.89% |
| Other Operating Expenses | -90.25% | -79.67% | -77.78% | -13.57% | -18.97% |
| Total Operating Expenses | -27.82% | -29.60% | -31.79% | -25.67% | -25.26% |
| Operating Income | 82.65% | 67.44% | 64.23% | 37.24% | 26.02% |
| Income Before Tax | 99.27% | 86.54% | 83.87% | 10.47% | 58.00% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 99.27% | 86.54% | 83.87% | 10.47% | 58.00% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 99.27% | 86.54% | 83.87% | 10.47% | 58.00% |
| EBIT | 82.65% | 67.44% | 64.23% | 37.24% | 26.02% |
| EBITDA | 98.01% | 78.56% | 71.00% | 44.09% | 32.83% |
| EPS Basic | 96.09% | 90.67% | 89.92% | -4.85% | 52.09% |
| Normalized Basic EPS | 94.43% | 85.93% | 84.99% | 38.11% | 37.41% |
| EPS Diluted | 96.08% | 90.67% | 89.92% | -4.80% | 52.16% |
| Normalized Diluted EPS | 94.43% | 85.93% | 84.99% | 38.11% | 37.41% |
| Average Basic Shares Outstanding | 124.93% | 129.70% | 164.74% | 63.63% | 73.40% |
| Average Diluted Shares Outstanding | 124.93% | 129.70% | 164.74% | 63.63% | 73.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | 0.81% | 0.01% |